Human toxicology evaluation of perfluorinated tensides (PFT) using Perfluorooctanoate (PFOA) and Perfluorosulfonate (PFOS) as examples;Humantoxikologische Bewertung Perfluorierter Tenside (PFT) am Beispiel der Perfluoroctansäure (PFOA) und der Perfluoroctansulfonsäure (PFOS)

Umweltmedizin in Forschung und Praxis

Volumn 12, Issue 2, 2007, Pages 95-104

  Dieter, Hermann H ^a  

^a UMWELTBUNDESAMT   (Germany)

Author keywords

Human toxicology evaluation; Perfluorinated tensides; Perfluorooctane sulfonic acid; Perfluorooctanoic acid; PFOA; PFOS

Indexed keywords

MACACA FASCICULARIS; MAMMALIA; RATTUS;

EID: 34250178456     PISSN: 14308681     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Andersen ME, Clewell HJ, III, Tan YM, Butenhoff JL, Olsen GW (2006): Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys - Probing the determinants of long plasma half-livers. Toxicology 227, 156-164
2. Butenhoff J, Costa G, Elcombe C, et al. (2002): Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months. Toxicological Sciences 69, 244-257
3. Butenhoff JL, Kennedy GL, Jr., Hinderliter PM, et al. (2004a): Pharmacokinetics of Perfluorooctanoate in Cynomolgus Monkeys. Toxicological Sciences 82, 394-406
4. Butenhoff JL, Gaylor DW, Moore JA, et al. (2004b): Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 39 (3), 363-380
5. Butenhoff JL, Olsen GW, Pfahles-Hutchens A (2006): The Applicability of Biomonitoring Data for Perfluorooctanesulfonate to the Environmental Public Health Continuum. Environmental Health Perspectives 114(11), 1776-1782
6. Calafat AM, Needham LL, Kuklenyik Z, et al. (2006): Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63, 490-496
7. Emmett EA, Shofer FS, Zhang H, Freeman D, Desai C, Shaw LM (2006a): Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48 (8), 759-770
8. Emmett EA, Zhang H, Shofer FS, et al. (2006b): Community Exposure to Perfluorooctanoate: Relationships between Serum Levels and certain Health Parameters. J Occup Environ Med 48 (8), 771-779
9. Fricke M, Lahl U (2005): Risikobewertung von Perfluortensiden als Beitrag zur aktuellen Diskussion zum REACH-Dossier der EU-Kommission. UWSF - Z Umweltchem Ökotox 17(1), 36-49
10. Fromme H, Midasch O, Twardella D, Angerer J, Boehmer S, Liebl B (2007): Occurrence of perfluorinated substances in an adult German population in southern Bavaria. Int Arch Occup Environ Health 80 (4), 313-319
11. Guo Y, Jolly RA, Halstead BW, et al. (2007): Underlying Mechanisms of Pharmacology and Toxicity of a Novel PPAR Agonist Revealed Using Rodent and Canine Hepatocytes. Toxicol Sci 96(2), 294-309
12. Guruge KS, Yeung LWY, Yamanaka N, et al. (2006): Gene Expression Profiles in Rat Liver Treated With Perfluorooctanoic Acid (PFOA). Toxicological Sciences 89 (1), 93-107
13. Han X, Snow TA, Kemper RA, Jepson GW (2003): Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16(6), 775-781
14. Harada K, Inoue K, Morikawa A, Yoshinaga T, Saito N, Koizumi A (2005): Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99 (2), 253-261
15. Harada K, Saito N, Inoue K, et al. (2004): The Influence of Time, Sex and Geographic Factors on Levels of Perfluorooctane Sulfonate and Perfluorooctanoate in Human Serum over the Last 25 years. J Occup Health 46, 141-147
16. Harada K, Saito N, Sasaki K, Inoue K, Koizumi A (2003): Perfluorooctane Sulfonate Contamination of Drinking Water in the Tama River, Japan: Estimated Effects on Resident Serum Levels. Bull Environ Contam Toxicol 71, 31-36
17. Hinderliter PM, DeLorme MP, Kennedy GL (2006): Perfluorooctanoic acid: Relationship between repeated inhalation exposures and plasma PFOA concentration in the rat. Toxicology 222, 80-85
18. st, 2007)
19. Kennedy GL Jr., Butenhoff JL,Olsen GW, et al. (2004):The Toxicology of Perfluorooctanoate. Critical Reviews in Toxicology 34 (4), 351-384
20. Kudo N, Suzuki-Nakajima E, Mitsumoto A, Kawashima Y (2006): Responses of the Liver to Perfluorinated Fatty Acids with Different Carbon Chain Length in Male and Female Mice: In Relation to Induction of Hepatomegaly, Peroxisomal â-Oxidation and Microsomal 1-Acylglycerophosphocholine Acyltransferase. Bio Pharm Bull 29 (9), 1952-1957
21. Lau C, Thibodeaux JR, Hanson RG, et al. (2006): Effects of Perfluorooctanoic Acid Exposure during Pregnancy in the Mouse.Toxicological Sciences 90 (2), 510-518
22. Loveless SE, Finlay C, Everds NE, et al. (2006): Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium Perfluorooctanoate (APFO). Toxicology 220 (2-3), 203-217
23. Luebker DJ, Hansen KJ, Bass NM, Butenhoff JL, Seacat AM (2002): Interactions of flurochemicals with rat liver fatty acid-binding protein. Toxicology 176, 175-185
24. Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL (2005a): Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: Dose-response, and biochemical and pharmacokinetic parameters. Toxicology 215, 149-169
25. Luebker DJ, Case MT, York RG, Moore JA, Hansen KJ, Butenhoff JL (2005b): Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215, 126-148
26. MAK, Deutsche Forschungsgemeinschaft - Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe (2006): Perfluoroctansäureundihre anorganischen Salze. In: Arbeitsmedizinische Begründungen, MAK, 41. Lieferung, 2006
27. Midasch O, Schettgen T, Angerer J (2006): Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. Int J Hyg Env Health 209 (6), 489-496
28. Nakayama S, Harada K, Inoue K, et al. (2005): Distributions of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) in Japan and Their Toxicities. Environmental Sciences 12 (6), 293-313
29. Niedersachsen (2007): Perfluorierte Alkylsubstanzen (PFAS) in der Muttermilch. Ergebnisse und vorläufige Bewertungen einer Pilotstudie des niedersächsischen Landesgesundheitsamtes. In: NLGA, Umwelt und Gesundheit, Report 3, S. 1-11, Stand 5. Juli 2006
30. OECD, Organisation for Economic Cooperation and Development (2002): Hazard Assessment of Perfluorooctane sulfonate (PFOS) and its salts. ENV/JM/RD(200217/FINAL, nov 21, 2002
31. Ohmori K, Kudo N, Katayama K, Kawashima Y (2003): Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184, 135-140
32. Olsen GW, Huang HY, Helzlsouer KJ, Hansen KJ, Butenhoff JL, Mandel JH (2005): Historical Comparsion of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood. Environmental Health Perspectives 113 (5), 539-545
33. Olsen GW, Mair DC, Reagen WK, et al. (2007): Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere, 2007 Jan 29 (Epub ahead of print)
34. Perkins RG, Butenhoff JL, Kennedy GL, Jr., Palazzolo MJ (2004): 13Week Dietary Toxicity Study of Ammonium Perfluorooctanoate (APFO) in Male Rats. Drug and Chemical Toxicology 27 (4), 361-378
35. Schulte C (2006): In-Thema: Perfluorierte Verbindungen. UWSF - Z Umweltchem Ökotox 18(3) 149-150
36. Skutlarek D, Exner M, Färber H (2006): Perfluorierte Tenside (PFT) in der aquatischen umweit und im trinkwasser. UWSF - Z Umweltchem Ökotox 18(3): 151-154
37. So MK, Yamashita N, Taniyasu S, et al. (2006): Health Risks in Infants Associated with Exposure to Perfluorinated Compounds in Human Breast Milkfrom Zhoushan, China. Environ Sci Technol 40, 2924-2929
38. TWK, Trinkwasserkommission des Bundesgesundheitsministeriums beim Umweltbundesamt (2006): Vorläufige Bewertung von Perfluorierten Tensiden (PFT) im Trinkwasser am Beispiel ihrer Leitsubstanzen Perfluoroctancarbonsä ure (PFOA) und Perfluoroctansulfonsäure (PFOS). Stellungnahme vom 21.06.06, überarbeitet am 13.07.06. www.umweltbundesamt.de/uba-info-presse/ hintergrund/pft-im-trinkwasser.pdf
39. UBA, Umweltbundesamt (2007): Perfluorierte Verbindungen - Falscher Alarm oder berechtigte Sorge? www.umweltbundesamt.de/uba-info-presse/hintergrund/ perfluorierte-verbindungen.pdf
40. Upham BL, Deocampo ND, Wurl B, Trosko JE (1998): Inhibition of Gap Junctional Intercellular Communication by Perfluorinated Fatty Acids is Dependent on the Chain Length of the Fluorinated Tail. Int J Cancer 78, 491-495
41. Wolf CJ, Fenton SE, Schmid JE, et al. (2007): Developmental Toxicity of Perfluorooctanoic Acid in the CD-1 Mouse after Cross-Foster and Restricted Gestational Exposures. Toxicological Sciences 95 (2), 462-473
42. Yao X, Zhong L (2005): Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mut Res 587, 38-44